KKKarmen Kissell

Karmen Kissell

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Karmen Kissell has a total of 5 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    A risk assessment of ethylene oxide release from a sterilization facility into a community

    by Quincy Perry, Karmen Kissell, Blake Deckard, Gale Hoffnagle, Dennis Paustenbach

    In recent decades, ethylene oxide (EtO) has been a widely used industrial sterilant and chemical intermediate that has faced increasing scrutiny related to its carcinogenic potential. This study evaluated residential and occupational exposure to EtO in a valley surrounding two point-source emissions in close proximity (~11 meters apart). Air samples were collected in residential and industrial areas. Eight locations, ranging from 100 to 1700 meters from the center of the point-sources in varying directions, had average concentrations between 0.290 and 3.212 µg/m3 (0.16 to 1.8 ppb) with peak levels reaching 26.4 µg/m3 (15 ppb). Exposure scenarios were developed based on daily activity patterns, long-term residency, and estimates derived from historical emissions data. Under the most conservative assumptions, including 40 years of occupational exposure during the periods of highest recorded emissions around the facility, the maximum estimated cumulative lifetime exposure was 591 ppm-days. When compared with epidemiology studies of EtO-exposed workers from similar facilities (studies used by the EPA and IARC in their cancer risk assessments), the highest cumulative exposures observed (13,500+ ppm-days) were at least 23-fold higher than our maximum estimated lifetime exposure value (591 ppm-days). Importantly, these high-exposure groups showed no statistically significant cancer incidence, particularly for breast and lymphohematopoietic cancers. When compared to regulatory values and health-based benchmarks adjusted to cumulative exposures, estimated exposures were substantially below levels associated with increased cancer incidence in epidemiological cohorts for the community surrounding the sterilization facility, even to the most susceptible populations.Implications: This study provides a data-driven, site-specific framework for evaluating long-term human health risks from ethylene oxide (EtO) emissions, using ambient air monitoring, historical emissions data, and conservative EPA-aligned exposure assumptions. Despite assessing one of the highest-emitting sterilization facilities in the U.S. estimated exposures remained well below levels linked to increased cancer risk in epidemiological studies. These findings challenge the assumption that facility proximity alone poses significant health risk and support the development of risk-based, proportionate air quality policies. The approach offers regulatory agencies a more transparent and scientifically grounded basis for EtO risk characterization under the Clean Air Act, TSCA, and state air toxics programs.


  • Open Access

    A comparative toxicological and epidemiological evaluation of dioxins and PFAS chemicals

    by Dennis Paustenbach, Karmen Kissell, Aryatara Shakya

    Regulatory frameworks, informed by robust and transparent scientific evidence, can significantly benefit society when thoughtful and measured regulation is promulgated. However, regulations founded on incomplete or misinterpreted science often result in unintended consequences. As was the case with the polychlorinated dibenzodioxin and polychlorinated dibenzofuran (PCDD/PCDF) chemicals, for the past 50 years, there has been a lack of scientific consensus on the adverse health effects of per- and polyfluoroalkyl substances (PFAS) in humans at current blood concentrations (about 4 ppb TEQ) or even concentrations 10-300-fold higher (40-1200 ppb TEQ). Despite their distinctly different chemical structures, the dioxins, particularly 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD), and perfluorooctanoic acid (PFOA)/perfluorooctanesulfonic acid (PFOS), share notable similarities: environmental persistence, biological recalcitrance, slightly unpredictable acute toxicity, a lack of genotoxicity, and suggestive data on adverse health effects in humans; across a wide range of doses. Both substances display varying degrees of acute toxicity across species, and both have been associated with the onset of wasting syndrome in certain animals at fairly high doses, but wasting syndrome is not seen in humans. Although there is moderate to high acute toxicity in multiple animal species for both families of chemicals, there is low acute toxicity in humans. In humans, both compounds interact with fatty acid metabolism. The evidence indicates that both are either weakly genotoxic or non-genotoxic. The dioxins can cause cancer in a variety of animal species, but even in humans exposed to high doses, no increased cancer risk is apparent. PFAS chemicals are similar; weakly carcinogenic in animals and, perhaps, lacking carcinogenic potency in humans. However, unlike with dioxins, high human exposure to PFAS has only occurred in the workplace; thus, few data from highly exposed human populations are available to rigorously evaluate the human cancer risk or other potential effects at elevated doses. Similar to the widespread presence of dioxins reported in the 1970s-1980s, PFAS chemicals are now globally ubiquitous, with detectable concentrations in nearly every individual, fish, and wildlife species. As awareness has increased over time, pressure to prevent the release or manufacture of PFOA and PFOS has decreased the blood concentrations in Americans by 10-fold over the past 15 years, paralleling trends observed with the dioxins when global concerns surfaced. The dioxins were regulated in a heavy-handed manner despite scientific uncertainty regarding their human health risks over a range of exposure levels, as well as a lack of consensus on dose-response relationships, thresholds for adverse effects, and human relevance of high-dose animal studies. The regulatory actions that occurred with the dioxins ultimately resulted in substantial economic and societal costs, even in the face of much uncertainty. This paper examines the parallels between the development of scientific understanding of the health hazards and the eventual regulation of dioxins and PFAS chemicals. For both families of chemicals, the precautionary principle was followed by most agencies rather than solid scientific data during the rulemaking process.